Esperion Therapeutics (ESPR) Non-cash Items (2012 - 2020)

Esperion Therapeutics has reported Non-cash Items for 9 years, with the latest figure at $3.2 million in Q2 2020.

• For the quarter ending Q2 2020, Non-cash Items rose 3.17% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2020 stood at $3.2 million (up 3.17% YoY), and the FY2019 full-year result was $3.0 million, down 96.41% from the prior year.
• Non-cash Items for Q2 2020 stood at $3.2 million, down from $31.1 million in the prior quarter.
• The five-year high for Non-cash Items was $165.4 million in Q4 2017, with the low at $1.4 million in Q2 2016.
• Historically, Non-cash Items has averaged $43.6 million across 5 years, with a median of $7.2 million in 2016.
• Annual changes were most pronounced in 2017 — Non-cash Items jumped 7129.11% — and 2019, when it sank 96.01%.
• Esperion Therapeutics' Non-cash Items stood at $5.2 million in 2016, then surged by 3071.94% to $165.4 million in 2017, then plunged by 49.53% to $83.5 million in 2018, then soared by 30.65% to $109.1 million in 2019, then slumped by 97.07% to $3.2 million in 2020.
• The last three Non-cash Items figures came in at $3.2 million (Q2 2020), $31.1 million (Q1 2020), and $109.1 million (Q4 2019), per Business Quant data.